deacetoxyvinzolidine has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acs, T; Cascante, M; Comin, B; Keve, T; Kovács, J; Orosz, F; Ovádi, J; Puigjaner, J; Raïs, B; Tárkányi, G | 1 |
| Agell, N; Bachs, O; Cascante, M; Comín-Anduix, B; Ovádi, J | 1 |
2 other study(ies) available for deacetoxyvinzolidine and Neuroblastoma
| Article | Year |
|---|---|
New semisynthetic vinca alkaloids: chemical, biochemical and cellular studies.
Topics: Animals; Antineoplastic Agents, Phytogenic; Calmodulin; Carcinoma, Ehrlich Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Microtubules; Neuroblastoma; Structure-Activity Relationship; Vinblastine | 1999 |
A new bis-indole, KARs, induces selective M arrest with specific spindle aberration in neuroblastoma cell line SH-SY5Y.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; CDC2 Protein Kinase; Cell Division; Chromosomes; Cyclin A; Cyclin B; Cyclin B1; G2 Phase; Humans; Interphase; Microtubules; Mitosis; Neuroblastoma; Spindle Apparatus; Tumor Cells, Cultured; Vinblastine | 2001 |